Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
Latest News
Zentek (ZTEK.V) took a years long path to figure out its incredible biotech potential
Tesla stock to $100?
Top 5 Gainers and Losers: KASH.CN, DHR.V, BRO.V
Standard Uranium (STND.V) looks to add to Sun Dog’s uranium history
Top 5 Gainers and Losers: SEI.V, LAB.V, NCU.TO
West High Yield Resources (WHY.V) announces milestone for Magnesium Project